By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Two European Union-funded research groups that will spend €12 million ($17.2 million) for colon and breast cancer research and development programs have awarded Agendia €1.3 million to develop molecular diagnostics for guiding personalized treatments, the company said today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.